Figure 4.
Figure 4. Expression of Eμ- and VavP-Bcl2 transgenes in lymphoid cells. (A) Flow cytometric analysis of transgenic Bcl2 detected by immunofluorescence staining with Bcl2-100 antibody in B220+ spleen cells. Cells from C57BL/6 mice served as the negative control. (B) Transgenic Bcl2 in B220+ B cells and Thy-1+ CD4+ and CD8+ T cells from the spleen. C57BL/6 (n = 10), Eμ-Bcl2 22 (n = 5), and Eμ-Bcl2 36 (n = 5) mice were compared with pooled data from 3 strains of VavP-Bcl2 mice (total n = 16). Fluorescence intensity values were normalized for nonspecific staining using nontransgenic C57BL/6 controls.

Expression of Eμ- and VavP-Bcl2 transgenes in lymphoid cells. (A) Flow cytometric analysis of transgenic Bcl2 detected by immunofluorescence staining with Bcl2-100 antibody in B220+ spleen cells. Cells from C57BL/6 mice served as the negative control. (B) Transgenic Bcl2 in B220+ B cells and Thy-1+ CD4+ and CD8+ T cells from the spleen. C57BL/6 (n = 10), Eμ-Bcl2 22 (n = 5), and Eμ-Bcl2 36 (n = 5) mice were compared with pooled data from 3 strains of VavP-Bcl2 mice (total n = 16). Fluorescence intensity values were normalized for nonspecific staining using nontransgenic C57BL/6 controls.

Close Modal

or Create an Account

Close Modal
Close Modal